WallStreetZenWallStreetZen

NASDAQ: VKTX
Viking Therapeutics Inc Earnings & Revenue

VKTX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$85.9M
Current Profit Margin
0%

VKTX Return on Equity

Current Company
-27.8%
Current Industry
-63.6%
Current Market
188%
VKTX's Return on Equity (-27.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when VKTX announces earnings.

VKTX Return on Assets

Current Company
-26.4%
Current Industry
3%
VKTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

VKTX Return on Capital Employed

Current Company
-24.59%
Current Industry
19.6%
VKTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VKTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
VKTX$0.00-$85.60M-$85.90MN/AN/A
ROIV$123.24M$4.58B$4.47B+41.90%N/A
ASND$286.79M-$442.12M-$517.68M+89.39%N/A
CERE$0.00-$416.15M-$432.84MN/AN/A
JAZZ$3.83B$1.22B$414.83M+15.19%-2.54%

VKTX earnings dates

Next earnings date
Apr 24, 2024

Viking Therapeutics Earnings & Revenue FAQ

What were VKTX's earnings last quarter?

On Invalid Date, Viking Therapeutics (NASDAQ: VKTX) reported Q4 2023 earnings per share (EPS) of -$0.25, up 3.85% year over year. Total Viking Therapeutics earnings for the quarter were -$24.61 million. In the same quarter last year, Viking Therapeutics's earnings per share (EPS) was -$0.26.

If you're new to stock investing, here's how to buy Viking Therapeutics stock.

What was VKTX's earnings growth in the past year?

As of Q1 2024, Viking Therapeutics's earnings has grown year over year. Viking Therapeutics's earnings in the past year totalled -$85.90 million.

What is VKTX's earnings date?

Viking Therapeutics's earnings date is Invalid Date. Add VKTX to your watchlist to be reminded of VKTX's next earnings announcement.

What was VKTX's revenue last quarter?

On Invalid Date, Viking Therapeutics (NASDAQ: VKTX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Viking Therapeutics's revenue was $0.00.

What was VKTX's revenue growth in the past year?

As of Q1 2024, Viking Therapeutics's revenue has grown null year over year. Viking Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.